GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Lemaitre Vascular, Inc. (LMAT) [hlAlert]

Rating:
Buy LMAT
up 68.05 %

Lemaitre Vascular, Inc. (LMAT) rated Buy with price target $17 by Stifel

Posted on: Friday,  Dec 4, 2015  8:25 AM ET by Stifel

Stifel rated Buy Lemaitre Vascular, Inc. (NASDAQ: LMAT) on 12/04/2015. Previously Stifel rated Buy Lemaitre Vascular, Inc. (NASDAQ: LMAT) on 06/24/2014.,
when the stock price was $7.92. Since then, Lemaitre Vascular, Inc. has gained 68.06% as of 01/20/2016's recent price of $13.31.
If you would have followed the previous Stifel's recommendation on LMAT, you would have gained 68.05% of your investment in 575 days.

LeMaitre Vascular, Inc. (LeMaitre Vascular) is a provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices. Its diversified portfolio of peripheral vascular devices consists of products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt-Inahara Carotid Shunt, and VascuTape Radiopaque Tape. The Company offers 14 product lines in three categories, namely Endascular, vascular and general surgery. Its products include thoracic stent grafts, abdominal stent grafts, anastomotic clips, radiopaque tape, valvulotomes, carotid shunts, arterial prostheses, remote endarterectomy devices, covered stents, contrast injectors, balloon catheters, vascular grafts, vein strippers, cholangiogram catheters and vascular access ports.

Stifel
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2015 8:25 AM Buy
None
15.26 17.00
as of 8/27/2015
1 Week up  0.83 %
1 Month up  21.11 %
3 Months up  33.10 %
1 YTD up  68.05 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/24/2014 12:00 AM Buy
None
7.92 11.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy